ResearcherChinese Academy of SciencesActive in the last 2 years
Aiguo Wu
Matched on ORCID iD 0000-0001-7200-8923; OpenAlex author ID A5021213624, A5103389430. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 5
- Dual-pathway blockade overcomes ferroptosis resistance in pancreatic ductal adenocarcinoma via a CD133-targeted manganese-porphyrin theranostic nanoplatform. Co-author DOI 10.1016/j.biomaterials.2026.124340↗
- Nanomaterial-assisted pancreatic cancer theranostics. Co-author DOI 10.1093/rb/rbaf054↗
- VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancreatic cancer. Last author DOI 10.1016/j.mtbio.2024.101106↗
- Advancements in SERS‐based biological detection and its application and perspectives in pancreatic cancer Co-author DOI 10.1002/viw.20230070↗
- Black TiO2-based nanoprobes for T1-weighted MRI-guided photothermal therapy in CD133 high expressed pancreatic cancer stem-like cells. Last author DOI 10.1039/c8bm00454d↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kaiwei Xu · 1 shared paper, 2026 · strength 0.27
- Jianhua Wang · 1 shared paper, 2026 · strength 0.27
- Yaqi Liu · 1 shared paper, 2025 · strength 0.25
- Qiang Li · 1 shared paper, 2025 · strength 0.25
- Lei Xu · 1 shared paper, 2023 · strength 0.24
- Tianan Jiang · 1 shared paper, 2023 · strength 0.24
- Lu Hong · 1 shared paper, 2024 · strength 0.19
- Lubing Zhu · 1 shared paper, 2024 · strength 0.19
- Jianhua Wang · 1 shared paper, 2024 · strength 0.19
- Kaiwei Xu · 1 shared paper, 2024 · strength 0.19
- Lufei Jin · 1 shared paper, 2024 · strength 0.19
- Siqi Wang · 1 shared paper, 2018 · strength 0.09
- Jianhua Wang · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.